Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPRISA 004: 1% Tenofovir Gel for HIV Prevention in Women
NCT00441298Phase 2Completed
- Sponsor
- CAPRISA
- Start
- May 2007
- Primary completion
- Dec 2009
- Modality
- Implantable Devices, Transdermal Patches, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir gel in human immunodeficiency virus infection (HIV), sponsored by CAPRISA. Started May 2007; status: completed.
02
Drugs
tenofovir gel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00441298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441298.